Angiotensin-Converting Enzyme Inhibitors and Angioedema: Estimating the Risk

Hypertension - United States
doi 10.1161/hypertensionaha.108.111393
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Angioedema, Angiotensin Converting Enzyme Inhibitors, and Angiotensin Receptor Blocking Drugs

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2007English

Angiotensin-Converting Enzyme and Dipeptidyl Peptidase IV Inhibitors: An Increased Risk of Angioedema

Hypertension
Internal Medicine
2009English

Angiotensin-Converting Enzyme Inhibitors-Induced Angioedema of the Small Bowel Mimicking Postoperative Complication

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2017English

Angiotensin Converting Enzyme (ACE) Inhibitors

Annual Review of Pharmacology and Toxicology
ToxicologyPharmacology
1982English

Dosage of Angiotensin Converting Enzyme Inhibitors

BMJ
1995English

A Method for Estimating the Potency of Angiotensin-Converting Enzyme Inhibitors in Man.

British Journal of Clinical Pharmacology
Pharmacology
1987English

Angiotensin Converting Enzyme Inhibitors and Diabetic Nephropathy.

BMJ
1992English

Airway Management in Angiotensin Converting Enzyme Inhibitor Related Angioedema

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2007English

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy